Moderate riskFDA DrugClass II

Aurobindo Dicyclomine Hydrochloride 10mg capsules recalled for empty capsules

Aurobindo Pharma USA is recalling Dicyclomine Hydrochloride Capsules 10mg (Batch DMC125018A, expiration 07/2027) because some bottles contain empty capsules instead of the medication. The issue affects approximately 6,408 bottles distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have Dicyclomine from this batch (look for NDC 59651-719-99 and batch number DMC125018A on the label).
  2. Do not take capsules from an affected bottle.
  3. Contact your pharmacy or doctor for a replacement or alternative medication.
  4. Return the affected bottle to your pharmacy.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
6,408 bottles distributed to market
Illnesses reported
None reported
Manufactured in
279 Princeton Hightstown Rd, East Windsor, NJ, United States
Classification
Class II
Recall number
D-0733-2026

In the FDA's words

Description
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99 shortfill; reports of empty capsules. Batch # DMC125018A, Exp Date: 07/2027. Distribution: US Nationwide. Affected quantity: 6,408 bottles distributed to market
Hazard
shortfill; reports of empty capsules.

More from Aurobindo Pharma

Related topics

PotencyDrugsSold nationwideMore from FDA Drug